Literature DB >> 77748

Problems encountered in the measurement of pregnancy-specific beta1-glycoprotein.

C M Towler, R G Glover, C H Horne.   

Abstract

Evidence is presented here that variants of the human trophoblastic plasma protein, pregnancy-specific beta1-glycoprotein (PSbetaG) are detectable in plasma samples from a small percentage of subjects and may be recognised by their capacity to form indistinct immunoprecipitates and give artificially low levels when measured by radioimmunoassay. Urinary PSbetaG shows a marked degree of heterogeneity and is difficult to measure using conventional immunoprecipitation assay techniques. By radioimmunoassay, late pregnancy urinary PSbetaG concentrations have been found to be in the range 0.35 to 6.9 microgram/ml, approximately 3% of the term plasma concentrations.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 77748     DOI: 10.1016/0009-8981(78)90350-9

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  2 in total

1.  Separation of two pregnancy-associated proteins with SP1 determinants and the conversion of SP1 beta to SP1 alpha.

Authors:  A G Ahmed; A Klopper
Journal:  Arch Gynecol       Date:  1980

2.  Serum levels of human placental lactogen and pregnancy-specific beta 1-glycoprotein in breast cancer.

Authors:  J C Monteiro; S Biswas; M A Al-Awqati; W P Greening; J A McKinna; A M Neville
Journal:  Br J Cancer       Date:  1982-08       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.